Clinical characteristics and outcomes of patients with COVID-19 on mechanical ventilation in Argentina
Not Applicable
Completed
- Conditions
- COVID-19 (SARS-CoV-2 infection)Infections and Infestations
- Registration Number
- ISRCTN78284710
- Lead Sponsor
- Sociedad Argentina de Terapia Intensiva (SATI)
- Brief Summary
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34224674/ (added 28/06/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1909
Inclusion Criteria
Consecutive adult patients admitted to participating ICUs who require mechanical ventilation and present confirmed COVID-19
Exclusion Criteria
Patients with severe respiratory infections/pneumonia due to another proven etiology
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hospital mortality: death of a patient (categorical binary data, 1 = nonsurvivor; and 0 = survivor) occurring at any time and in any site during hospitalization
- Secondary Outcome Measures
Name Time Method 1. 28-day mortality: death of a patient (categorical binary data, 1 = nonsurvivor; and 0 = survivor) occurring in any site of the hospital between hospital admission and day 28<br>2. Duration of mechanical ventilation: number of days of invasive mechanical ventilation measured as continuous data (in days), as the difference between the date of weaning from mechanical ventilation and the date of endotracheal intubation<br>3. Length of ICU stay: number of days measured as continuous data (in days), as the difference between the date of ICU discharge and the date of ICU admission<br>4. Length of hospital stay; number of days measured as continuous data (in days), as the difference between the date of hospital discharge and the date of hospital admission
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie severe COVID-19 requiring mechanical ventilation in Argentina?
How effective are observational cohort studies in identifying biomarkers for ventilator outcomes in SARS-CoV-2 infections?
What adverse events are associated with mechanical ventilation in South American ICU populations with SARS-CoV-2?
Are there specific drug targets identified in ISRCTN78284710 for treating ventilated COVID-19 patients?
How does the ISRCTN78284710 trial compare to other global studies on ventilated patients with RAS-CoV-2 variants?